Safety and Efficacy of Levomilnacipran Extended Release in Pediatric Patients Aged 7–17 Years with Major Depressive Disorder: Results of Two Phase 3, Randomized, Double-Blind Studies
2024 · Journal of Child and Adolescent Psychopharmacology · 5 citations
https://doi.org/10.1089/cap.2023.0080